InterDigital Inc (IDCC)

[walldiver]

OT-Slight correction...the Provenge vote was 17-0 for safety and 13-4 for efficacy. However, the two most vocal opponents of Provenge on the panel were the same two who wrote letters to the FDA afterward urging the agency not to approve, and were the only two voters who had to file conflict of interest waivers because of grant money accepted from Provenge's potential competitors.